Nyxoah SA current report, Q3 FY2022

Nyxoah SA — Form 6-K Summary

Reporting period: Third quarter 2022, ended September 30, 2022. The Form 6-K was furnished in November 2022 and announced unaudited third-quarter results. The submitted text includes the filing cover and exhibit descriptions but not the contents of Exhibits 99.1 and 99.2.

Business Context

Nyxoah SA, a Belgian medical technology company, furnished its third-quarter 2022 report and related press release under Form 6-K. The filing identifies the company as a foreign private issuer that files annual reports on Form 20-F.

Financial Metrics

  • Revenue: The filing text does not provide a clear value.
  • Profit or loss: The filing text does not provide a clear value.
  • Cash flow and cash balance: The filing text does not provide a clear value.
  • Margins: The filing text does not provide a clear value.
  • Debt and liquidity: The filing text does not provide a clear value.
  • Other operating or financial metrics: The filing text does not provide a clear value.

Material Changes Versus Prior Period

The submitted text does not include the underlying third-quarter report or press release, so material changes versus the prior comparable period cannot be assessed.

Guidance, Outlook, Risks, and Unusual Items

The filing cover states that unaudited third-quarter results were announced on November 8, 2022, but provides no guidance, outlook, risk disclosures, contingencies, or unusual items. Exhibits 99.1 and 99.2 are identified as the press release and third-quarter report, respectively, but their contents are not included in the supplied text.

Investor Verification Items

  • Obtain and review Exhibits 99.1 and 99.2 for revenue, operating results, cash position, cash burn, debt, and liquidity.
  • Verify any year-over-year and sequential changes for the quarter ended September 30, 2022.
  • Review management’s guidance, commercial progress, regulatory or clinical updates, and financing plans.
  • Confirm whether the third-quarter report contains material contingencies or going-concern-related disclosures.
  • Note that the filing states the furnished information is not deemed filed for purposes of Exchange Act Section 18 liability, except as otherwise expressly provided.